InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,471.05
(
1.16%
)
US TECH 100
18,204.80
(
1.43%
)
Dow Jones
40,829.59
(
1.20%
)
Brent Oil
71.34
(
-0.53%
)
Bitcoin
56,813.83
(
-0.37%
)
Post# of 43325
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

agmcsf

Send PM Follow Ignore
Followers 0
Posts 14
Boards Moderated 0
Alias Born 08/01/2020

agmcsf

Re: tscott4 post# 16825

Wednesday, 09/09/2020 6:15:24 AM

Wednesday, September 09, 2020 6:15:24 AM

Post# of 43325
Well, I just want to point out that Humanigen is relatively slow to finish the phase III study. For example, Roche start a 450 patients IL-6 study (NCT04320615) on April 3, and complete the trial on July 28. If Humanigen could have such speed, the phase III study could be completed in August. Also, Humanigen is heavily betted on COVID-19 trial, if the trial fails, I don't think Humanigen could raise enough money for another indication (~100M).
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up